Holt Capital Partners’s AbbVie ABBV Stock Holding History

Holt Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$773K	Buy	3,072 +1,872	+156%	+$403K	0.09%	106
2026 Q1	$261K	Hold	1,200	–	–	0.04%	149
2025 Q4	$274K	Hold	1,200	–	–	0.04%	144
2025 Q3	$278K	Hold	1,200	–	–	0.04%	137
2025 Q2	$223K	Hold	1,200	–	–	0.04%	144
2025 Q1	$251K	Hold	1,200	–	–	0.04%	147
2024 Q4	$213K	Sell	1,200 -120	-9%	-$22.1K	0.03%	149
2024 Q3	$261K	Buy	1,320 +20	+2%	+$3.73K	0.04%	145
2024 Q2	$223K	Sell	1,300 -184	-12%	-$30.5K	0.05%	139
2024 Q1	$270K	Buy	1,484 +34	+2%	+$5.86K	0.04%	144
2023 Q4	$225K	Hold	1,450	–	–	0.04%	149
2023 Q3	$216K	Buy	+1,450	New	+$213K	0.04%	145
2023 Q2	–	Sell	-1,750	Closed	-$279K	–	153
2023 Q1	$279K	Hold	1,750	–	–	0.06%	133
2022 Q4	$283K	Hold	1,750	–	–	0.06%	135
2022 Q3	$235K	Hold	1,750	–	–	0.07%	130
2022 Q2	$268K	Hold	1,750	–	–	0.06%	138
2022 Q1	$284K	Hold	1,750	–	–	0.05%	138
2021 Q4	$237K	Buy	+1,750	New	+$207K	0.04%	155
2016 Q2	–	Sell	-1,500	Closed	-$86K	–	126
2016 Q1	$86K	Buy	+1,500	New	+$83.6K	0.04%	162
2015 Q4	–	Sell	-1,500	Closed	-$82K	–	112
2015 Q3	$82K	Hold	1,500	–	–	0.03%	149
2015 Q2	$101K	Hold	1,500	–	–	0.04%	142
2015 Q1	$88K	Hold	1,500	–	–	0.04%	151
2014 Q4	$98K	Buy	+1,500	New	+$94.6K	0.04%	144
2014 Q3	–	Sell	-1,500	Closed	-$85K	–	107
2014 Q2	$85K	Buy	1,500 +600	+67%	+$31.5K	0.05%	125
2014 Q1	$46K	Hold	900	–	–	0.03%	182
2013 Q4	$48K	Buy	+900	New	+$44.2K	0.03%	181

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Holt Capital Partners's ABBV Position: Q2 2026 in Review

Holt Capital Partners increased its AbbVie (ABBV) stake by 156% in Q2 2026, buying an estimated $403K and bringing the position to 3,072 shares worth $773K. The position accounts for 0.09% of the portfolio, ranked #106.

Holt Capital Partners first reported a position in ABBV in Q4 2013 and has held it in 26 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Holt Capital Partners held 3,072 shares of AbbVie worth $773K as of Q2 2026.
Holt Capital Partners bought 1,872 AbbVie shares in Q2 2026, an estimated $403K.
AbbVie made up 0.09% of Holt Capital Partners's portfolio in Q2 2026, its #106 holding.
Holt Capital Partners first reported a position in AbbVie in Q4 2013 and has held it in 26 quarters since.
4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Holt Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.